新华社权威快报丨114种新药进入2025年国家医保药品目录

Core Points - The 2025 National Medical Insurance Drug List and the first version of the Commercial Insurance Innovative Drug List were released on December 7 in Guangzhou [3] - A total of 114 new drugs were added to the National Medical Insurance Drug List, with 50 being first-class innovative drugs, achieving an overall success rate of 88%, a significant increase from 76% in 2024 [3] - The new drug list includes medications for major diseases such as triple-negative breast cancer, pancreatic cancer, and lung cancer, as well as treatments for rare diseases and chronic conditions [3] Group 1 - The National Medical Insurance Drug List now includes a total of 3,253 drugs, comprising 1,857 Western medicines and 1,396 traditional Chinese medicines [3] - The inclusion of drugs in the Commercial Insurance Innovative Drug List includes 19 medications, such as CAR-T for cancer treatment and drugs for rare diseases like neuroblastoma and Gaucher disease [3] - The adjustment significantly enhances the coverage for key areas such as cancer, chronic diseases, mental health, rare diseases, and pediatric medications [3]